Codoxo
Company

Last deal

$20M

Amount

Series B

Stage

03.02.2022

Date

6

all rounds

$29.4M

Total amount

General

About Company
Codoxo, formerly known as Fraudscope, uses AI technology to improve the affordability and effectiveness of the healthcare system.

Industry

Sector :

Subsector :

Keywords :

Also Known As

FraudScope

founded date

01.01.2016

Number of employees

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

Codoxo's Forensic AI Platform, powered by a patented algorithm, detects and addresses problems and suspicious behavior in healthcare earlier than traditional methods, ensuring that limited healthcare funds are allocated to genuine patient care. Founded in 2016 and based in Atlanta, Georgia, Codoxo helps healthcare companies and agencies control costs by quickly identifying and responding to emerging issues before they have a significant impact on financial performance.
Contacts